🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Objectives: To understand whether the implementation of warfarin dose mana...
Status
Unknown
Location
Multiple Locations
Start Date
2020-08
Trial ID
NCT04510805
Treatments Being Tested
This is a clinical study designed to test the hypothesis that a computer mo...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-01-01
Trial ID
NCT03962400
Treatments Being Tested
In the US, patients receiving warfarin therapy are rarely allowed to engage...
Status
Unknown
Location
VA Loma Linda Healthcare System
Start Date
2023-03-15
Trial ID
NCT04766216
Treatments Being Tested
Several human genes affect how medications are metabolized by the body. It ...
Status
Completed
Location
University of Utah Health Care
Start Date
2006-09
Trial ID
NCT00634907
Treatments Being Tested
The purpose of this study is to demonstrate the feasibility and effectivene...
Status
Completed
Location
University of Illinois at Chicago
Start Date
2016-01
Trial ID
NCT02776566
Treatments Being Tested
Can a simple and cost-free tool help family physicians to improve dosing of...
Status
Completed
Location
Caroline Medical Group
Start Date
2009-10
Trial ID
NCT01008215
Treatments Being Tested
Warfarin (also called Coumadin®) is an anticoagulant drug (blood thinner) g...
Status
Withdrawn
Location
Shands at the University of Florida
Start Date
2006-07
Trial ID
NCT00377143
Treatments Being Tested
Warfarin is the most commonly used oral anticoagulant medicine (blood thinn...
Status
Completed
Location
University of Utah
Start Date
2009-08
Trial ID
NCT00993200
Treatments Being Tested
(a) To explore the feasibility and utility of implementing broad preemptive...
Status
Recruiting
Location
The University of Illinois at Chicago
Start Date
2017-11-09
Trial ID
NCT03225820
This study aims to explore the feasibility of a novel, patient-specific alg...
Status
Completed
Location
University of Utah Thrombosis Center
Start Date
2018-11-20
Trial ID
NCT03911661
Treatments Being Tested